Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0959 | 0.5 |
Brugia malayi | Disco-interacting protein 2 homolog | 0.0041 | 0.2948 | 0.2948 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0959 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.2469 | 0.7303 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0959 | 0.2838 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.338 | 0.338 |
Schistosoma mansoni | DNA (cytosine-5)-methyltransferase | 0.0021 | 0.1155 | 0.3417 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0959 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.338 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0959 | 0.0959 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.2469 | 0.2469 |
Echinococcus multilocularis | cpg binding protein | 0.0035 | 0.2469 | 0.7303 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0959 | 0.5 |
Entamoeba histolytica | DNA (cytosine-5)-methyltransferase, putative | 0.0021 | 0.1155 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0089 | 0.735 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0959 | 0.2838 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.2469 | 0.7303 |
Echinococcus granulosus | DNA methyltransferase 2, putative | 0.0021 | 0.1155 | 0.3417 |
Trypanosoma brucei | cytosine-specific DNA methylase, putative | 0.0021 | 0.1155 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0118 | 1 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0959 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.338 | 1 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0089 | 0.735 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.338 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0118 | 1 | 1 |
Echinococcus multilocularis | DNA methyltransferase 2, putative | 0.0021 | 0.1155 | 0.3417 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0959 | 0.5 |
Echinococcus granulosus | disco interacting protein 2 | 0.0041 | 0.2948 | 0.872 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0959 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.338 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.338 | 1 |
Echinococcus multilocularis | disco interacting protein 2 | 0.0041 | 0.2948 | 0.872 |
Schistosoma mansoni | disco-interacting protein 2 (dip2) | 0.0041 | 0.2948 | 0.872 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.2469 | 0.2469 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.2469 | 0.7303 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.338 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0959 | 0.2838 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.2948 | 0.2948 |
Leishmania major | modification methylase-like protein | 0.0021 | 0.1155 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0959 | 0.0959 |
Plasmodium vivax | DNA (cytosine-5)-methyltransferase, putative | 0.0021 | 0.1155 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.338 | 1 |
Toxoplasma gondii | DNA methyltransferase 2, putative | 0.0021 | 0.1155 | 0.0306 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0959 | 0.5 |
Plasmodium falciparum | DNA (cytosine-5)-methyltransferase | 0.0021 | 0.1155 | 0.0306 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0959 | 0.2838 |
Echinococcus granulosus | cpg binding protein | 0.0035 | 0.2469 | 0.7303 |
Onchocerca volvulus | 0.0041 | 0.2948 | 1 | |
Toxoplasma gondii | C-5 cytosine-specific DNA methylase superfamily protein | 0.0021 | 0.1155 | 0.0306 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.338 | 0.338 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0959 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI (functional) | = 0 % | Growth inhibition of human K562 cells at 1 uM after 24 hrs by MTT assay relative to control | ChEMBL. | 22136905 |
GI (ADMET) | = 1 % | Growth inhibition of human HEK293 cells at 1 uM after 24 hrs by MTT assay relative to control | ChEMBL. | 22136905 |
GI (ADMET) | = 2.5 % | Growth inhibition of human HEK293 cells at 10 uM after 24 hrs by MTT assay relative to control | ChEMBL. | 22136905 |
GI (functional) | = 24 % | Growth inhibition of human K562 cells at 10 uM after 24 hrs by MTT assay relative to control | ChEMBL. | 22136905 |
GI (functional) | = 37.1 % | Growth inhibition of human COLO205 cells at 1 uM after 24 hrs by MTT assay relative to control | ChEMBL. | 22136905 |
GI (functional) | = 47.9 % | Growth inhibition of human COLO205 cells at 10 uM after 24 hrs by MTT assay relative to control | ChEMBL. | 22136905 |
IC50 (functional) | = 10 uM | Cytotoxicity against human COLO205 cells after 24 hrs by MTT assay | ChEMBL. | 22136905 |
IC50 (functional) | = 24 uM | Cytotoxicity against human K562 cells after 24 hrs by MTT assay | ChEMBL. | 22136905 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 22136905 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.